Adalimumab Mouse, Clone: 15C7, GenScript™

Mouse Monoclonal Antibody

Supplier:  Genscript Corporation A0195440

Catalog No. 50-212-0676

Description

Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL. Adalimumab, sold under the trade name Humira among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic psoriasis, hidradenitis suppurativa, and juvenile idiopathic arthritis. Adalimumab is a TNF-inhibiting, anti-inflammatory, biologic medication. It binds to tumor necrosis factor-alpha (TNFalpha), which normally binds to TNFalpha receptors, leading to the inflammatory response of autoimmune diseases. By binding to TNFalpha, adalimumab reduces this inflammatory response. Because TNFalpha is also part of the immune system, which protects the body from infection, treatment with adalimumab may increase the risk of infections.

Adalimumab Monoclonal antibody specifically detects Adalimumab in Chemical samples. It is validated for ELISA

Specifications

• Antigen: Adalimumab
• Classification: Monoclonal
• Conjugate: Unconjugated
• Gene Alias: Humira
• Immunogen: Adalimumab
• Quantity: 40 μg
• Primary or Secondary: Primary
• Product Type: Antibody
• Isotype: IgG2b κ

• Applications: ELISA
• Clone: 15C7
• Formulation: PBS with 0.02% sodium azide; pH 7.4
• Host Species: Mouse
• Purification Method: Protein A
• Regulatory Status: RUO
• Content And Storage: -20°C or -80°C if preferred
• Form: Lyophilized
• Target Molecule: Chemical